A model validation and consensus building environment

被引:17
作者
Abshear, T. [1 ]
Banik, G. M. [1 ]
D'Souza, M. L. [1 ]
Nedwed, K. [1 ]
Peng, C. [1 ]
机构
[1] Bio Rad Labs Inc, Philadelphia, PA 19104 USA
关键词
model; validation; consensus; intrinsic water solubility; plasma-protein binding; mutagenicity;
D O I
10.1080/10659360600787551
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Over half of the failures in drug development are due to problems with the absorption, distribution, metabolism, excretion, and toxicity, or ADME/Tox properties of a candidate compound. The utilization of in silico tools to predict ADME/Tox and physicochemical properties holds great potential for reducing the attrition rate in drug research and development, as this technology can prioritize candidate compounds in the pharmaceutical R&D pipeline. However, a major concern surrounding the use of in silico ADME/Tox technology is the reliability of the property predictions. Bio-Rad Laboratories, Inc. has created a computational environment that addresses these concerns. This environment is referred to as KnowItAll (R). Within this platform are encoded a number of ADME/Tox predictors, the ability to validate these predictors with/without in-house data and models, as well as build a 'consensus' model that may be a much better model than any of the individual predictive model. The KnowItAll (R) system can handle two types of predictions: real number and categorical classification.
引用
收藏
页码:311 / 321
页数:11
相关论文
共 21 条
[1]  
BANIK GM, 2004, CURR DRUG DISCOV, P31
[2]  
BANIK GM, 2003, ADME TOX CONSENSUS P
[3]   2D QSAR consensus prediction for high-throughput virtual screening. An application to COX-2 inhibition modeling and screening of the NCI database [J].
Baurin, N ;
Mozziconacci, JC ;
Arnoult, E ;
Chavatte, P ;
Marot, C ;
Morin-Allory, L .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (01) :276-285
[4]  
BENGIO Y, ESTIMATORS VARIANCE
[5]   Drug discovery [J].
Brennan, MB .
CHEMICAL & ENGINEERING NEWS, 2000, 78 (23) :63-+
[6]  
DEARDEN JC, 2002, J PHARM PHARMACOL, V54, pS2
[7]   Managing the drug discovery/development interface [J].
Kennedy, T .
DRUG DISCOVERY TODAY, 1997, 2 (10) :436-444
[8]  
MALLELA R, 2003, CHI PRED ADME TOX C
[9]  
MALLELA R, 2004, SHEFF CHEM C SHEFF U
[10]   Predicting the genotoxicity of secondary and aromatic amines using data subsetting to generate a model ensemble [J].
Mattioni, BE ;
Kauffman, GW ;
Jurs, PC ;
Custer, LL ;
Durham, SK ;
Pearl, GM .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (03) :949-963